Cite
HARVARD Citation
Tu, M. et al. (2019). Corrigendum to 'Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2' [Cancer Lett. 2016 Dec 28; 383 (2):272–281]. Cancer letters. pp. 189-190. [Online].